Definitive Contract 75F40126C00027
Award Date 8/12/26
Potential Completion Date 8/11/27
Potential Value $1.9M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
8(a) Sole Source
Extent Competed
Not Available for Competition
Major Defense Program
Not listed Pricing Type
Labor Hours
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration (FDA) awarded an 8(a) sole source contract to Aneon Brillient, LLC, a minority-owned small disadvantaged business, for CDER science database administration support. The $485,507.74 labor-hour contract has an ultimate completion date of August 13, 2029. Aneon Brillient, LLC specializes in providing professional services to federal agencies, particularly the FDA, in areas such as medical product development, drug evaluation, and policy support. This award is...
- This is a $164,940.82 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned small disadvantaged business. The contract is for database administration support for the FDA's Center for Drug Evaluation and Research (CDER). The contract is a labor-hour type with a completion date of September 25, 2026. Aneon Brillient, an SBA certified 8(a) joint venture, has extensive experience providing professional services to the FDA, including...
- The Food and Drug Administration awarded a definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for shipping, receiving, printing support, and administrative support services to the Office of Regulatory Affairs Office of Training, Education, and Development on September 17, 2024, under an 8(a) sole-source set-aside with a ceiling value of $409,085.88. Work is performed in Reston, Virginia, under a labor-hours pricing structure. The contract extends through March...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business certified as an SBA 8(a) joint venture. The contract is for $164,005.68 to provide communications support services for the Immediate Office of the FDA Commissioner, with a period of performance through July 13, 2026. Aneon Brillient, LLC is a limited liability company based in Reston, Virginia that specializes in providing...
- <p>The Food and Drug Administration awarded a $4.198 million definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for supply chain technical support services to the Center for Drug Evaluation and Research (CDER) on August 28, 2025, under a direct 8(a) award.</p> <p>The contract is a labor-hour type with a 9.5-month base period and two 12-month options, extending through June 15, 2028. Place of performance is Beltsville, Maryland.</p>
- The Food and Drug Administration awarded a $2.13 million definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for medical and scientific writing and editing services supporting the Center for Drug Evaluation and Research (CDER) on August 21, 2024, under a direct 8(a) award. The contract is a labor-hour engagement with a ceiling value of $2,133,514.80 and ultimate completion date of August 27, 2028. Place of performance is Calverton, Maryland. In fiscal 2024, the...
- The Food and Drug Administration (FDA) awarded a definitive contract to Aneon Brillient, LLC on February 28, 2024, to provide transcription services supporting the Center for Drug Evaluation and Research (CDER) Advisory Committee meetings. The contract, set aside as an 8(a) sole source award, carries a ceiling value of approximately $642.5K and extends through February 27, 2027. Under this labor-hour contract, Aneon Brillient will deliver transcription services and support materials necessary...
- This is a sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Aneon Brillient, LLC, a minority-owned, small disadvantaged business. The objective of the contract is to provide webmaster, technical, and creative support to enhance and maintain OTED's online presence and assist in fulfilling the OTED Director's or their designee web content manager's requirements. The contract has a ceiling value of $229,132.68 and a performance period through August 14, 2025. Aneon...
- This is a labor hour award to Brillient Corporation, a minority-owned business, for oncology center for excellence (OCE) training and communications professional services for the Food and Drug Administration (FDA). The contract was awarded on July 1, 2020 and has a potential value of $233,218.32. It is a Blanket Purchase Agreement (BPA) call under the Professional Services Schedule (PSS) contract vehicle. The Department of Health and Human Services (HHS) FDA is the funding agency. Brillient will...
- The Food and Drug Administration awarded a $182,302.83 definitive contract to Aneon Brillient, LLC, an SBA-certified 8(a) joint venture, for quality management system services on July 17, 2024, under an 8(a) sole-source set-aside. The contract is a one-year labor-hour engagement supporting the Center for Drug Evaluation and Research, Office of Pharmacy, and is structured as time-and-materials pricing. Work is performed in St. Louis, Missouri. The ultimate completion date is August 6, 2025.